GSK will begin shipping its quadrivalent influenza vaccines to US healthcare providers and pharmacies for the 2019-20 flu season, immediately following licensing and lot-release approval from the US Food and Drug Administration's (FDA) Center for Biologic
The report to identify and analyse emerging trends along with major drivers, challenges and opportunities in the global influenza market. Also highlights key development and new drugs launched by various companies across the globe.